EPISODE · Jul 14, 2026 · 5 MIN
Real-World Decision Points in Biomarker-Driven NSCLC Management
from Oncology Learning Network · host HMP Global
Dr Jamie Chaft discusses how longitudinal biomarker assessment can support treatment planning, resistance evaluation, and rebiopsy decision-making in NSCLC. Key topics include disease progression, tissue limitations, prior assay results, multidisciplinary collaboration, and individualized testing strategies.
Embed this episode
Ready to play
Real-World Decision Points in Biomarker-Driven NSCLC Management
0:00
5:17
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Oncology Learning Network?
This episode is 5 minutes long.
When was this Oncology Learning Network episode published?
This episode was published on July 14, 2026.
Can I download this Oncology Learning Network episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!